Exact Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Exact Sciences has a total shareholder equity of $3.2B and total debt of $2.6B, which brings its debt-to-equity ratio to 80.4%. Its total assets and total liabilities are $6.7B and $3.5B respectively.
Key information
80.4%
Debt to equity ratio
US$2.57b
Debt
| Interest coverage ratio | n/a |
| Cash | US$946.78m |
| Equity | US$3.19b |
| Total liabilities | US$3.48b |
| Total assets | US$6.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EXAS *'s short term assets ($1.5B) exceed its short term liabilities ($668.6M).
Long Term Liabilities: EXAS *'s short term assets ($1.5B) do not cover its long term liabilities ($2.8B).
Debt to Equity History and Analysis
Debt Level: EXAS *'s net debt to equity ratio (50.7%) is considered high.
Reducing Debt: EXAS *'s debt to equity ratio has reduced from 105.3% to 80.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EXAS * has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if EXAS * has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.